Mellitus

0 followers


Mellitus is developing a novel in vitro diagnostic test for the measurement of Glycated CD59 (GCD59) with potential clinical utility in screening, diagnosis and monitoring of diabetes, stratification of complications risk and as a clinical trial test for pharmaceutical development. Mellitus' lead pr... Read more

Industries

Headquarters

Stage

Employees

Links

Org chart

John Tagliamonte

Collapse
Rick Saul
Head of Product Development
Kathy Welch
Head of Finance
Christopher de Souza
Board Director
Michael Chorev
Founder and Board member
Shailendra Kumar, Ph.D
Chief Scientific Officer